Knockdown of RARγ expression in immortalized epithelial MCF-10A (ER-, non-tumorigenic), MCF-7 (ER+, tumorigenic) and MDA-MB-231 (ER-, PR- and HER2-,tumorigenic) breast cancer cell lines led to their reduced proliferation. The gene discussed is ERBB2; the disease is breast cancer.